ID/IQ parent award for pharmacology and toxicology for therapeutics program (pttp)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95021D00026
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 9 $4,944,967 obligated
Award facts
- Opportunity
-
- Pharmacology and Toxicology for Therapeutics Program (PTTP) Pre-Solicitation · NIHNINDS75N95021R00017 · Posted Feb 3, 2021
- Combined order value
-
- $5,027,095 Current, with exercised options
- $7,294,033 Potential, with all options
- Last date to order 85% complete
- IDV ceiling 3% used
- $174,470,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Neurological Disorders and Stroke awarded a single-award indefinite-delivery contract to IIT Research Institute for $174.47 million on September 29, 2021, for the Pharmacology and Toxicology for Therapeutics Program.
Place of performance is Chicago, Illinois. The contract funds non-GLP absorption, distribution, metabolism, and excretion (ADME) / pharmacokinetic / toxicology studies; GLP IND-enabling toxicology; and safety pharmacology assessments supporting investigational new drug development across up to 10 non-GLP projects and 5 GLP projects annually. Contractor must maintain GLP-compliant laboratory capability, AAALAC accreditation, and animal welfare assurance, with capacity to conduct studies in rodents, dogs, rabbits, non-human primates, and other animal models.
Period of performance runs September 29, 2021, through September 12, 2027. The contract ceiling is $174.47 million with no stated minimum guarantee.
Recent task-order activity includes a $3.39 million cost-plus-fixed-fee delivery order issued by NINDS on June 25, 2026, for GLP and non-GLP toxicology studies (completion December 25, 2027); a $442,623 cost-plus-fixed-fee order issued by the National Institute on Drug Abuse on September 26, 2025, for rodent and non-rodent dose-range-finding and median-tolerated-dose studies (completion September 25, 2026); a $473,586 cost-plus-fixed-fee order issued by NINDS on March 1, 2024, for dose-range-finding studies (completion February 28, 2025); and a $224,716 cost-plus-fixed-fee order issued by NINDS on March 15, 2024, for dog dose-range-finding studies (completion December 15, 2024). IIT Research Institute is a non-profit subsidiary of Illinois Institute of Technology and operates as a direct prime contractor delivering preclinical research services through direct employment with minimal subcontracting.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Definitize Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Modification | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract 75N95021D00026?
75N95021D00026 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2021.
How much is contract 75N95021D00026 worth?
Orders under 75N95021D00026 have obligated $4,944,967. Their combined current value, with exercised options, is $5,027,095. Their combined potential value, with all options, is $7,294,033. 75N95021D00026's own ceiling is $174,470,000.
How many orders have been placed under contract 75N95021D00026?
9 orders have been placed under 75N95021D00026, the latest on September 15, 2026.
Which agency awarded contract 75N95021D00026?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021D00026, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract 75N95021D00026?
75N95021D00026 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95021D00026 competed?
The extent of competition for 75N95021D00026 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV